Literature DB >> 30080744

Predictors of Successful Weaning From Veno-Arterial Extracorporeal Membrane Oxygenation After Coronary Revascularization for Acute Myocardial Infarction Complicated by Cardiac Arrest: A Retrospective Multicenter Study.

Atsushi Sugiura1, Ryuzo Abe2, Takashi Nakayama1, Noriyuki Hattori2, Yoshihide Fujimoto1, Toshiharu Himi3, Koichi Sano4, Shigeto Oda2, Yoshio Kobayashi1.   

Abstract

AIM: While veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been utilized to resuscitate and stabilize hemodynamics in patients of acute myocardial infarction (AMI) complicated by cardiac arrest (CA), it is essential to predict the possibility of weaning from ECMO to determine further strategies, including use of ventricular assist device. We aimed to determine predictors of successful weaning from VA-ECMO in the early phase of ECMO treatment.
METHODS: We identified consecutive patients of AMI complicated by CA treated with VA-ECMO and percutaneous coronary intervention (PCI). Clinical data within 48 h after ECMO initiation were assessed and multiple logistic regression analysis was performed to determine independent predictors of weaning outcome.
RESULTS: Fifty-five patients were analyzed. While 28 (51%) patients were successfully weaned from VA-ECMO, 27 (49%) failed to wean. Multivariate analysis identified post-PCI thrombolysis in myocardial infarction (TIMI) flow grade (P = 0.046), mean arterial pressure (MAP) at 4 h after ECMO initiation (P = 0.010), and serum lactate at 24 h (P = 0.015) as independent predictors of successful weaning. Left ventricular ejection fraction (LVEF) at 24 and 48 h was significantly greater in the successful weaning group (P = 0.014, P = 0.025, respectively).
CONCLUSIONS: Successful weaning from VA-ECMO was predicted by post-PCI TIMI flow grade, MAP at 4 h, and serum lactate at 24 h after VA-ECMO initiation in patients of AMI complicated by CA. Furthermore, in patients who failed to wean from ECMO, LVEF did not recover within 48 h. In such patients, adjunctive use of other circulatory mechanical devices must be considered.

Entities:  

Mesh:

Year:  2019        PMID: 30080744     DOI: 10.1097/SHK.0000000000001220

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.

Authors:  Yu-Wen Chen; Wei-Chieh Lee; Po-Jui Wu; Hsiu-Yu Fang; Yen-Nan Fang; Huang-Chung Chen; Meng-Shen Tong; Pei-Hsun Sung; Chieh-Ho Lee; Wen-Jung Chung
Journal:  Front Cardiovasc Med       Date:  2022-06-30

2.  Assessment of cardiac recovery in patients supported with venoarterial extracorporeal membrane oxygenation.

Authors:  Ravi Vuthoori; Cassandra Heaney; Brian Lima; Alexis Knisel; Ed Miller; Kevin Kennedy; David Majure; Gerin Stevens; Karl Bocchieri; Hugh Cassiere; Harold Fernandez; Simon Maybaum
Journal:  ESC Heart Fail       Date:  2022-04-22

3.  Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.

Authors:  Jeffrey A Marbach; Pietro Di Santo; Navin K Kapur; Katherine L Thayer; Trevor Simard; Richard G Jung; Simon Parlow; Omar Abdel-Razek; Shannon M Fernando; Marino Labinaz; Michael Froeschl; Rebecca Mathew; Benjamin Hibbert
Journal:  J Am Heart Assoc       Date:  2022-03-09       Impact factor: 6.106

4.  Predictors of weaning failure in case of VA ECMO implantation.

Authors:  Axelle Cusanno; Nadia Aissaoui; Vincent Minville; Jean Porterie; Caroline Biendel; Kim Volle; Laure Crognier; Jean-Marie Conil; Clément Delmas
Journal:  Sci Rep       Date:  2022-08-16       Impact factor: 4.996

5.  Hyperglycemia and Thrombocytopenia - Combinatorially Increase the Risk of Mortality in Patients With Acute Myocardial Infarction Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation.

Authors:  Yusuke Okadome; Jun Morinaga; Hirotaka Fukami; Kota Hori; Teruhiko Ito; Michio Sato; Keishi Miyata; Takashige Kuwabara; Masashi Mukoyama; Ryusuke Suzuki; Ryusuke Tsunoda; Yuichi Oike
Journal:  Circ Rep       Date:  2021-10-27

6.  Levosimendan in venoarterial ECMO weaning. Rational and design of a randomized double blind multicentre trial.

Authors:  Omar Ellouze; Agnès Soudry Faure; Mohamed Radhouani; Osama Abou-Arab; Emmanuel Besnier; Mouhamed Moussa; Amélie Cransac; Elea Ksiazek; Marc-Olivier Fischer; Paul Michel Mertes; Belaid Bouhemad; Pierre Grégoire Guinot
Journal:  ESC Heart Fail       Date:  2021-06-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.